The International Liver Congress

April 13-17, 2016
Barcelona, Spain

ILC-BannerDNDi launched its new Research & Development Strategy for Hepatitis C at the International Liver Congress (ILC) on April 13th.



Press Briefing

Date: April 13, 2016



  • Dr Bernard Pécoul, Executive Director, Drugs for Neglected Diseases initiative
  • Dr Sherine Helmy, President, Pharco Cooperation
  • Dr Shahnaz Murad, Deputy Director General of Health, Research & Technical Support, Ministry of Health Malaysia


The Drugs for Neglected Disease initiative announced an important agreement at the International Liver Conference in Barcelona with the Egyptian drug manufacturer Pharco to develop affordable hepatitis C regimens for the millions of people left behind the research and development revolution for hepatitis C.




For more information, please contact:

Ilan Moss
Communications Manager
Drugs for Neglected Diseases initiative – North America
M: +1 646 266 5216 |


More information: ILC Website